Breast Cancer Clinical Trial
Study of Calgranulin A/B Levels in Patients With Newly Diagnosed Stage I,II,III Breast Cancer
Summary
RATIONALE: Measuring levels of calgranulin A and calgranulin B in the blood of patients with breast cancer in the laboratory may help doctors identify and learn more about biomarkers related to breast cancer.
PURPOSE: This laboratory study is measuring calgranulin A and calgranulin B levels in the blood of patients with newly diagnosed stage I, stage II, or stage III breast cancer.
Full Description
OBJECTIVES:
Determine circulating levels of calgranulin A and calgranulin B in patients with estrogen receptor negative or estrogen receptor positive, newly diagnosed, primary stage I-III adenocarcinoma of the breast.
OUTLINE: This is a pilot study.
Patients undergo a blood draw following diagnosis of breast cancer to assess levels of circulating tumor markers, calgranulin A and calgranulin B. Serum samples are evaluated by enzyme-linked immunosorbent assay for tumor marker expression.
PROJECTED ACCRUAL: A total of 60 patients will be accrued for this study.
Eligibility Criteria
DISEASE CHARACTERISTICS:
Histologically confirmed primary adenocarcinoma of the breast
Stage I-III disease
No evidence of metastatic disease
Newly diagnosed disease
Hormone receptor status:
Estrogen receptor-positive- or -negative tumor
PATIENT CHARACTERISTICS:
Sex
Not specified
Menopausal status
Not specified
Performance status
Not specified
Life expectancy
Not specified
Hematopoietic
Not specified
Hepatic
Not specified
Renal
Not specified
Other
Not pregnant
No Crohn's disease
No arthritis
No psoriasis
No lupus erythematosus
No multiple sclerosis
No other severe active inflammation
Not C-reactive protein positive
No HIV positivity
No other serious medical or psychiatric illness
PRIOR CONCURRENT THERAPY:
Radiotherapy
No prior radiotherapy for breast cancer
Surgery
No prior organ transplantation
Other
No prior systemic therapy for breast cancer
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Cleveland Ohio, 44106, United States
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.